Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [APLS] Apellis Pharmaceuticals Inc
Data updated 2025-Oct-24 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Oct-24 Friday
| Open | $28.61 | High | $28.98 +1.29% |
|---|---|---|---|
| Close | $28.17 | Low | $28.05 -1.96% |
| Volume | 1.27 Million 1.23x | Volatility | 3.32% |
| Change |
$-0.44
-1.54%
|
Streak | ↓ 1 days -1.54% |
| 20d SMA | $25.11 +12.2% | 50d SMA | $25.60 +10.0% | 100d SMA | $22.82 +23.4% | 200d SMA | $23.10 +22.0% |
| RSI | 64 | MACD | 0.51 | ADX | 29.0 | Stochastic Oscillator | 88.6 90.7 |
| CCI | 147.0 | ATR | 1.25 | OBV | -54.6 Million | Chaikin A/D | -39.3 Million |
| Market Cap | 6.75 B | PEG Ratio | Trailing P/E | Forward P/E | |||
| Price/Sales (ttm) | 16.7 | Price/Book (mrq) | 34.7 | EV/Revenue (ttm) | 16.4 | EV/EBITDA (ttm) | -13.1 |
| % Held by Insiders | 13.23% | % Held by Institutions | 96.00% | Shares Short | 10.6 M | Shares Short (prior month) | 10.3 M |
| Short Ratio | 7.54 | Short % of Outstanding | 8.78% | Short % of Float | 13.07% | Shares Short Change (mom) | +3.1% |
| Revenue/Share (ttm) | $3.34 | Profit Margin (ttm) | -133.29% | Operating Margin (ttm) | -57.74% | EBITDA (ttm) | -515 M |
| Diluted EPS (ttm) | $-4.45 | Current Ratio (mrq) | 3.1 | Return on Assets (ttm) | -41.73% | Return on Equity (ttm) | -290.14% |
| Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 545.90% | Operating Cash Flow (ttm) | -595 M | Free Cash Flow (ttm) | -405 M | |
Choose view type
Daily Performance for Apellis Pharmaceuticals Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Apellis Pharmaceuticals Inc up to close of 2025-Oct-24 at $28.17
| Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
|---|---|---|---|---|---|---|---|---|
|
01 Trailing 5-days
|
|
+14.89%
|
-3.2%
|
+13.6%
|
17.4%
|
+0.4%
|
+1.6%
|
1.23x
|
|
02 Trailing 10-days
|
|
+12.14%
|
-3.2%
|
+21.9%
|
26.0%
|
+7.7%
|
+5.3%
|
0.95x
|
|
03 Trailing 20-days
|
|
+25.93%
|
-3.2%
|
+27.1%
|
31.3%
|
+12.2%
|
+9.2%
|
1.07x
|
|
04 Trailing 30-days
|
|
+13.36%
|
-3.2%
|
+33.7%
|
38.2%
|
+15.2%
|
+10.9%
|
1.05x
|
|
05 Trailing 50-days
|
|
+1.99%
|
-3.2%
|
+33.7%
|
38.2%
|
+10.0%
|
+13.5%
|
0.97x
|
|
06 Trailing 100-days
|
|
+49.68%
|
-3.2%
|
+64.3%
|
69.7%
|
+23.4%
|
+17.7%
|
1.01x
|
|
07 Trailing 200-days
|
|
-18.65%
|
-18.3%
|
+75.0%
|
114.2%
|
+22.0%
|
+12.0%
|
0.92x
|
|
08 Month-to-date
|
|
+24.48%
|
-3.2%
|
+23.6%
|
27.7%
|
|
|
|
|
09 Quarter-to-date
|
|
+24.48%
|
-3.2%
|
+23.6%
|
27.7%
|
|
|
|
|
10 Year-to-date
|
|
-11.72%
|
-20.8%
|
+75.0%
|
120.9%
|
|
|
|
|
11 Trailing 52-weeks
|
|
+2.14%
|
-21.1%
|
+75.0%
|
121.9%
|
|
|
|
1-week Performance Benchmarks for Apellis Pharmaceuticals Inc:
Related to Apellis Pharmaceuticals Inc
Information for Apellis Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Oct-24 on Google
SEC Reports : Quarterly reports around 2025-Oct-24 on SEC Edgar
Compare Apellis Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Apellis Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Apellis Pharmaceuticals Inc